Navigation Links
Kendle Executive to Share Insights at World Pharma Trials Asia 2010
Date:3/17/2010

CINCINNATI, March 17 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced Dr. Ross Horsburgh, Vice President, Asia/Pacific will address the World Pharma Trials Asia 2010 conference being held March 17-18, 2010 at the Raffles City Convention Centre in Singapore. Dr. Horsburgh's presentation, "Accelerating Oncology Clinical Development in Asia," is scheduled for March 18 at 2 p.m. local time.  World Pharma Trials Asia brings together pharmaceutical companies, biotechnology companies and CROs to explore outsourcing opportunities in Asia.

Dr. Horsburgh's presentation will explore key opportunities and challenges in oncology development in the region, discuss the benefits of including Asian countries in global development plans for oncology, define key success factors for conducting these trials in Asia and discuss best practices in selecting the optimal sites for exploratory oncology trials.  

Following the conference, Dr. Horsburgh's presentation will be posted to the Kendle Web site at http://www.kendle.com/RW_media_show.php?cid=6.

Dr. Horsburgh is a trained medical physician with more than 20 years of experience in the CRO and pharmaceutical industries.  He is responsible for the strategic oversight of all of Kendle's operations throughout the Asia/Pacific region, which includes offices in Beijing, Hong Kong and Shanghai, China; Ahmedabad and New Delhi, India; Kuala Lumpur, Malaysia; Bangkok, Thailand; Manila, Philippines; Sydney and Melbourne, Australia and Singapore.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.

SOURCE Kendle International Inc.

Back to top

RELATED LINKS
http://www.kendle.com

'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate
2. Kendle Launches New Global Biostatistics Infrastructure
3. Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone
4. Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
5. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
6. Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition
7. Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
8. ThermalTherapeutic Systems, Inc. Announces the Addition of Former MEDRAD Executive Alan Hirschman, PhD to the Board of Directors
9. Yvonne Verburgt Joins the Avrio Executive Team as Vice President of Business Development and Marketing
10. Top Bristol-Myers Squibb Executive Joins Patton Boggs
11. Babson Executive Education Offers Bio-Pharma: Mastering the Business of Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
Breaking Medicine Technology:
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing skills ... patients and their families pay tribute to a genetic counselor by nominating him or ... Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome magazine ...
Breaking Medicine News(10 mins):